Cosmos Health Stock to Reverse Split on Thursday, November 12th (NASDAQ:COSM)

Shares of Cosmos Health Inc. (NASDAQ:COSM) are scheduled to reverse split on the morning of Thursday, November 12th. The 1-20 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Wednesday, November 11th.

Cosmos Health Price Performance

COSM stock traded up $0.04 during trading on Wednesday, hitting $0.24. The stock had a trading volume of 2,110,844 shares, compared to its average volume of 4,099,442. The stock has a market cap of $23.76 million, a price-to-earnings ratio of -0.37 and a beta of 4.73. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.92 and a current ratio of 1.05. The company’s 50 day moving average price is $0.31 and its two-hundred day moving average price is $0.30. Cosmos Health has a 1-year low of $0.16 and a 1-year high of $0.77.

Cosmos Health (NASDAQ:COSM) last released its quarterly earnings results on Tuesday, August 18th. The company reported ($0.10) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.10). The company had revenue of $19.32 million for the quarter, compared to analysts’ expectations of $18.99 million. Cosmos Health had a negative net margin of 33.08% and a negative return on equity of 56.88%. On average, sell-side analysts forecast that Cosmos Health will post -0.15 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

COSM has been the topic of several recent analyst reports. Noble Financial initiated coverage on shares of Cosmos Health in a research note on Monday, October 26th. They set an “outperform” rating on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cosmos Health in a research note on Wednesday, October 28th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold”.

Hedge Funds Weigh In On Cosmos Health

An institutional investor recently bought a new stake in Cosmos Health stock. BlackRock Inc. acquired a new stake in shares of Cosmos Health Inc. (NASDAQ:COSM) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 267,797 shares of the company’s stock, valued at approximately $49,000. BlackRock Inc. owned 0.45% of Cosmos Health as of its most recent SEC filing. 12.61% of the stock is currently owned by institutional investors and hedge funds.

Cosmos Health Company Profile

Cosmos Health Inc. is a healthcare group that develops, manufactures and distributes pharmaceutical, nutraceutical and healthcare products. Its portfolio includes branded dietary supplements, vitamins and wellness products, as well as pharmaceutical products and medical devices distributed through retail, wholesale and online channels. The company markets its nutraceutical products under the Sky Premium Life brand, which offers supplements and other health and wellness products. Cosmos Health also has manufacturing and product-development activities through Cana Laboratories, a Greece-based pharmaceutical manufacturer that produces pharmaceutical and healthcare products for its own portfolio and third parties.